UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (102) 102
life sciences & biomedicine (100) 100
oncology (87) 87
humans (83) 83
mutation (46) 46
lung neoplasms - genetics (45) 45
male (41) 41
female (40) 40
lung neoplasms - drug therapy (38) 38
carcinoma, non-small-cell lung - genetics (33) 33
lung neoplasms - pathology (33) 33
middle aged (33) 33
aged (29) 29
carcinoma, non-small-cell lung - drug therapy (29) 29
lung cancer (27) 27
adult (26) 26
antineoplastic agents - therapeutic use (23) 23
carcinoma, non-small-cell lung - pathology (23) 23
protein kinase inhibitors - therapeutic use (23) 23
receptor, epidermal growth factor - genetics (23) 23
aged, 80 and over (20) 20
respiratory system (17) 17
drug resistance, neoplasm - genetics (13) 13
egfr (13) 13
genotype (13) 13
neoplasm staging (13) 13
receptor, epidermal growth factor - antagonists & inhibitors (13) 13
retrospective studies (13) 13
abridged index medicus (11) 11
cancer (11) 11
cell line, tumor (11) 11
disease progression (11) 11
drug resistance, neoplasm (11) 11
erbb receptors - genetics (11) 11
lung cancer, non-small cell (11) 11
molecular targeted therapy (11) 11
prognosis (11) 11
treatment outcome (11) 11
tumors (11) 11
antineoplastic agents - pharmacology (10) 10
care and treatment (10) 10
lung neoplasms - mortality (10) 10
non-small cell lung cancer (10) 10
respiratory tract diseases (10) 10
erlotinib hydrochloride (9) 9
nsclc (9) 9
protein kinase inhibitors - pharmacology (9) 9
quinazolines - therapeutic use (9) 9
adenocarcinoma - genetics (8) 8
diagnosis (8) 8
erlotinib (8) 8
non-small cell lung carcinoma (8) 8
pulmonary and respiratory medicine (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
carcinoma, non-small-cell lung - mortality (7) 7
drug resistance (7) 7
epidermal growth factor receptors (7) 7
follow-up studies (7) 7
patients (7) 7
research (7) 7
adenocarcinoma - drug therapy (6) 6
adenocarcinoma of lung (6) 6
analysis (6) 6
animals (6) 6
clinical trials (6) 6
gefitinib (6) 6
general & internal medicine (6) 6
health aspects (6) 6
medicine, general & internal (6) 6
medicine, research & experimental (6) 6
physics (6) 6
research & experimental medicine (6) 6
risk factors (6) 6
survival rate (6) 6
carcinoma, non-small-cell lung - therapy (5) 5
chemotherapy (5) 5
computed tomography (5) 5
deoxyribonucleic acid--dna (5) 5
epidermal growth factor (5) 5
erbb receptors - antagonists & inhibitors (5) 5
exons (5) 5
genomics (5) 5
high-throughput nucleotide sequencing (5) 5
lung neoplasms - blood (5) 5
lung neoplasms - diagnosis (5) 5
lung neoplasms - diagnostic imaging (5) 5
mutation - genetics (5) 5
polymerase chain reaction - methods (5) 5
proto-oncogene proteins p21 - genetics (5) 5
t790m (5) 5
targeted therapy (5) 5
tyrosine (5) 5
acquired resistance (4) 4
adenocarcinoma - pathology (4) 4
alleles (4) 4
antibodies, monoclonal - therapeutic use (4) 4
beer (4) 4
biochemistry (4) 4
biomarkers (4) 4
calculating (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical cancer research, ISSN 1078-0432, 09/2011, Volume 17, Issue 17, pp. 5530 - 5537
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2015, Volume 372, Issue 18, pp. 1700 - 1709
Patients with non–small-cell lung cancer and mutated epidermal growth factor receptors who develop resistance to EGFR inhibitors through a particular mutation... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Humans | Middle Aged | ErbB Receptors - genetics | Lung Neoplasms - pathology | Male | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Acrylamides - pharmacokinetics | Dose-Response Relationship, Drug | Hyperglycemia - chemically induced | Antineoplastic Agents - adverse effects | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Protein Kinase Inhibitors - pharmacokinetics | ErbB Receptors - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - genetics | Pyrimidines - administration & dosage | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Acrylamides - administration & dosage | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Acrylamides - adverse effects | Clinical trials | Care and treatment | Usage | Diagnosis | Lung cancer, Non-small cell | Hyperglycemia | Chemotherapy | Epidermal growth factor | Inhibitor drugs | Epidermal growth factor receptors | Lung cancer | Genes | Non-small cell lung carcinoma | Antitumor activity | Pharmacokinetics | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 1538-7445, 05/2017, Volume 77, Issue 10, pp. 2712 - 2721
Insertion mutations in EGFR and HER2 both occur at analogous positions in exon 20. Non-small cell lung cancer (NSCLC) patients with tumors harboring these... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Receptor, ErbB-2 - genetics | Exons | Humans | Middle Aged | Molecular Conformation | Receptor, ErbB-2 - chemistry | Male | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Dose-Response Relationship, Drug | Protein Kinase Inhibitors - chemistry | Codon | Adult | Female | Antineoplastic Agents - pharmacology | Receptor, ErbB-2 - antagonists & inhibitors | Disease Models, Animal | Lung Neoplasms - genetics | Gene Expression | Models, Molecular | Treatment Outcome | Antineoplastic Agents - chemistry | Receptor, Epidermal Growth Factor - chemistry | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Protein Kinase Inhibitors - therapeutic use | Cell Line, Tumor | Protein Binding | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Mutagenesis, Insertional | Protein Kinase Inhibitors - pharmacology | Lung Neoplasms - diagnosis | Amino Acid Substitution | Epidermal growth factor receptors | Lung cancer | Insertion | Non-small cell lung carcinoma | Drug resistance | Patients | ErbB-2 protein | Mutants | Sensitivity | Covalence | Inhibitors | Mutation | Tumors | Cancer | Index Medicus | human epidermal growth factor receptor 2 | drug resistance | tyrosine kinase inhibitor | exon 20 | Epidermal growth factor receptor
Journal Article
Journal Article